Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 studyShubham Pant, Christophe Le Tourneau, Ademi Santiago-Walker et al.|The Lancet Oncology|2023Cited by 195